| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/15/2002 | EP1205477A1 Mutual prodrug of amlodipine and atorvastatin |
| 05/15/2002 | EP1205475A1 Flavonoid compounds for use against oxidative stress and UV radiation |
| 05/15/2002 | EP1205218A1 Topical antipsoriaticum comprising urea, a corticoid and a desinfectant |
| 05/15/2002 | EP1205191A1 Targeted modification of intracellular compounds |
| 05/15/2002 | EP1205189A2 Combination of a prostaglandin agonist and a HMG-CoA reductase inhibitor for the stimulation of bone growth |
| 05/15/2002 | EP1205187A1 Remedies for neurogenic pains |
| 05/15/2002 | EP1205183A2 Antimicrobial composition containing cellulose acetate |
| 05/15/2002 | EP1205182A2 Adenosine as antithrombotic |
| 05/15/2002 | EP1205181A2 Composition and method for parenteral administration of ibuprofen D, L-or L-Lysine salt |
| 05/15/2002 | EP1205178A2 Conjugate, method for its production and use thereof |
| 05/15/2002 | EP1205177A2 Conjugate, method for its production and use thereof |
| 05/15/2002 | EP1205175A1 Hair mousse with long-lasting effect |
| 05/15/2002 | EP1204870A2 Method for determining physiological effects of hemoglobin |
| 05/15/2002 | EP1204868A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 05/15/2002 | EP1204764A2 Methods of screening for angiogenesis modulators |
| 05/15/2002 | EP1204745A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 05/15/2002 | EP1204742A2 Oligonucleotides for inhibiting the expression of human eg5 |
| 05/15/2002 | EP1204682A2 Compositions and methods for the treatment of tumors |
| 05/15/2002 | EP1204678A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 05/15/2002 | EP1204675A1 Streptogramin derivatives, production thereof and compositions containing the same |
| 05/15/2002 | EP1204674A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 05/15/2002 | EP1204670A2 Antibiotic agents |
| 05/15/2002 | EP1204669A1 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration |
| 05/15/2002 | EP1204667A1 An improved amorphous form of cefpodoxime proxetil |
| 05/15/2002 | EP1204666A1 Hexahydropyrrolo[1,2-c]pyrimidines as antiviral, antifungal and/or antitumor agents |
| 05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204663A1 Novel spiro compounds |
| 05/15/2002 | EP1204662A1 Azaindoles having serotonin receptor affinity |
| 05/15/2002 | EP1204660A1 Serotonergic benzothiophenes |
| 05/15/2002 | EP1204659A2 Serotonergic benzofurans |
| 05/15/2002 | EP1204658A1 Benzofurylpiperazine serotonin agonists |
| 05/15/2002 | EP1204657A1 Piperidine and pyrrolidine derivatives displaying neuronal activity |
| 05/15/2002 | EP1204656A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride |
| 05/15/2002 | EP1204655A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 05/15/2002 | EP1204654A1 Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
| 05/15/2002 | EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/15/2002 | EP1204650A1 Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 05/15/2002 | EP1204649A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 05/15/2002 | EP1204646A1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | EP1204641A1 4-aminopiperidine derivatives of tetrahydronaphthalene, chromans and thiochromans |
| 05/15/2002 | EP1204626A1 Ether compounds, compositions, and uses thereof |
| 05/15/2002 | EP1204434A1 Tissue augmentation material and methods |
| 05/15/2002 | EP1204430A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 05/15/2002 | EP1204426A2 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
| 05/15/2002 | EP1204416A1 Carnitine analogues as topical, microbicidal spermicides |
| 05/15/2002 | EP1204414A2 Use of morphinan derivates as medicines |
| 05/15/2002 | EP1204413A2 Control of crustacean infestation of aquatic animals |
| 05/15/2002 | EP1204412A2 Use of etodolac to treat cancer |
| 05/15/2002 | EP1204409A1 Microparticles for pulmonary administration |
| 05/15/2002 | EP1204408A2 An improved form of form i celiprolol hydrochloride |
| 05/15/2002 | EP1204407A2 Implantable active ingredient depot |
| 05/15/2002 | EP1204406A2 Opioid sustained-released formulation |
| 05/15/2002 | EP1204404A1 Composition for topical administration comprising 5-methoxypsoralen |
| 05/15/2002 | EP1204332A1 Aspartic and malic acid inhibition of beta-glucuronidase |
| 05/15/2002 | EP1177797A9 Novel use |
| 05/15/2002 | EP1167360A9 Human chymase inhibitors |
| 05/15/2002 | EP1161247A4 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 05/15/2002 | EP1102594B1 Use of sodium chloride to reduce the gastrointestinal toxicity of camptothecin derivatives |
| 05/15/2002 | EP1091659B1 Oral form of administration |
| 05/15/2002 | EP1082028B1 Matthiola seed oil, mixtures containing it and use thereof |
| 05/15/2002 | EP1071745A4 Process for synthesizing cox-2 inhibitors |
| 05/15/2002 | EP1071401A4 Liposomal bupivacaine compositions and methods of preparation |
| 05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 05/15/2002 | EP1032391B1 Spheroids containing tiagabine, preparation process and pharmaceutical compositions |
| 05/15/2002 | EP1019067A4 Methods of using emu oil and active fractions thereof as an insect repellent |
| 05/15/2002 | EP0963201B1 Transdermal application of naturally occurring steroid hormones |
| 05/15/2002 | EP0923549B1 Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use |
| 05/15/2002 | EP0885234B1 Novel erythromycin derivatives, method for preparing same, and use thereof as drugs |
| 05/15/2002 | EP0883622B1 Proton pump inhibitor |
| 05/15/2002 | EP0865278B1 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
| 05/15/2002 | EP0809504B1 Anti-viral triazacyclododecane |
| 05/15/2002 | EP0805813B1 Tricyclic vasopressin antagonists |
| 05/15/2002 | EP0792163B1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
| 05/15/2002 | EP0778833B1 Endothelin receptor antagonists |
| 05/15/2002 | EP0751775B1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives |
| 05/15/2002 | EP0748314B1 Tetrasubstituted imidazole derivatives, method for preparing the same, use thereof as drugs, and pharmaceutical compositions containing the same |
| 05/15/2002 | EP0733621B1 Novel imidazole derivative and process for producing the same |
| 05/15/2002 | EP0730443B1 Suspension of loteprednol etabonate |
| 05/15/2002 | EP0729460B1 Substituted 5-ring heterocycles, their preparation and their use |
| 05/15/2002 | EP0706513B1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 05/15/2002 | EP0617623B1 Transdermally administered system containing acetylsalicylic acid for thrombosis therapy |
| 05/15/2002 | EP0611565B1 Use of a composition for dermatologic preparation |
| 05/15/2002 | CN1349560A Avermectin aglycon synthase genes |
| 05/15/2002 | CN1349542A Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 05/15/2002 | CN1349541A L-ribo-LNA analogues |
| 05/15/2002 | CN1349540A Antifungal ethers |
| 05/15/2002 | CN1349538A Cyclocarbamate and cyclic amide derivatives |
| 05/15/2002 | CN1349537A Cyclic urea and cyclic amide derivatives |
| 05/15/2002 | CN1349536A Thienopyrimidine compounds, their production and use |
| 05/15/2002 | CN1349535A Bicyclic heteroaromatic compounds useful as LH agonists |
| 05/15/2002 | CN1349534A 6-alkenyl-, 6-alkinyl-and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 05/15/2002 | CN1349533A Heteroaryl diazabicycloalkanes, their prepn. and use |
| 05/15/2002 | CN1349531A Cyanopyrroles as progesterone receptor agonists |
| 05/15/2002 | CN1349530A 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 05/15/2002 | CN1349529A Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa |
| 05/15/2002 | CN1349528A Pyrimidine compounds |
| 05/15/2002 | CN1349527A Substituted benzolactam compounds |
| 05/15/2002 | CN1349525A Di-aryl acid derivatives as PPAR receptor ligands |
| 05/15/2002 | CN1349524A Renin inhibitors |